Applications for membership in SVS are due by March 1 and will be considered during the 2017 Vascular Annual Meeting, May 31-June 3. VAM is the only time each year that the Society votes on membership applications. Don’t delay; apply today.
The 2017 Medicare Physician Fee Schedule Final Rule includes many changes beneficial to SVS members, following many months of work, including submission of comments, by SVS members and advocacy staff. The schedule was released on Nov. 2, 2016.
Between all the Vascular Annual Meeting has to offer and all that host city San Diego boasts, forgive California SVS surgeons, particularly those in the San Diego area, if they’re looking forward to summer.
While Dr. Michael Dalsing doesn’t have a crystal ball, he is nonetheless making two predictions in the wake of the November presidential election:
Dr. Venita Chandra has some simple advice for those mulling membership in the Society for Vascular Surgery: Don’t hesitate. At all.
Surgery is dangerous for cigarette smokers. If your surgeon recommends surgery, smoking cessation is a must. Ask for help if you need it.
The Society for Vascular Surgery and the Society for Vascular Nursing have signed an agreement in which the nursing association will be managed from the Chicago-based SVS office.
Dear Friends:
Thank you for all your support, past and present, of the SVS and its many different missions. You are part of an amazing organization, and its success is due to you and each member of our Society.
Here’s the most important advice you will get from the program committee chair: Submit early.
Participants at the Vascular Annual Meeting (VAM) have lots more to look forward to than sunny skies, beaches and palm trees. A number of new program features are planned to add interest and value to the meeting, said Dr. Ron Dalman.
Preliminary available data from the groundbreaking CREST-2 trial indicate the value and positive results of intensive medical therapy, whether patients also received revascularization as well, said Dr. Brajesh K. Lal, principal investigator.
Applications for membership in SVS are due by March 1 and will be considered during the 2017 Vascular Annual Meeting, May 31-June 3. VAM is the only time each year that the Society votes on membership applications. Don’t delay; apply today.
The 2017 Medicare Physician Fee Schedule Final Rule includes many changes beneficial to SVS members, following many months of work, including submission of comments, by SVS members and advocacy staff. The schedule was released on Nov. 2, 2016.
Between all the Vascular Annual Meeting has to offer and all that host city San Diego boasts, forgive California SVS surgeons, particularly those in the San Diego area, if they’re looking forward to summer.
While Dr. Michael Dalsing doesn’t have a crystal ball, he is nonetheless making two predictions in the wake of the November presidential election:
Dr. Venita Chandra has some simple advice for those mulling membership in the Society for Vascular Surgery: Don’t hesitate. At all.
Surgery is dangerous for cigarette smokers. If your surgeon recommends surgery, smoking cessation is a must. Ask for help if you need it.
The Society for Vascular Surgery and the Society for Vascular Nursing have signed an agreement in which the nursing association will be managed from the Chicago-based SVS office.
Dear Friends:
Thank you for all your support, past and present, of the SVS and its many different missions. You are part of an amazing organization, and its success is due to you and each member of our Society.
Here’s the most important advice you will get from the program committee chair: Submit early.
Participants at the Vascular Annual Meeting (VAM) have lots more to look forward to than sunny skies, beaches and palm trees. A number of new program features are planned to add interest and value to the meeting, said Dr. Ron Dalman.
Preliminary available data from the groundbreaking CREST-2 trial indicate the value and positive results of intensive medical therapy, whether patients also received revascularization as well, said Dr. Brajesh K. Lal, principal investigator.